Clinical Trial

Chrono-restricted Diet and Physical Activity as a New Preventive Strategy for Sarcopenia in Postmenopausal Women With Obesity and Type 2 Diabetes

Study acronym: TIMEDIAB
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of TIMEDIAB is to demonstrate that early TRE (eTRE) combined to late (afternoon) exercise will outperform eTRE combined to morning exercise on muscle function as primary endpoint, and glucose homeostasis as secondary endpoint
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-10.
Trial Details
NCT Number NCT07075133
Lead Sponsor University Hospital, Toulouse
Conditions Obesity, Sarcopenia, Post Menopause, Type 2 Diabetes, Circadian Clock
Enrollment 45 participants
Start Date 2026-09-15
Primary Completion 2029-07-15 (estimated)
Study Completion 2029-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-01